Technologies Available for Licensing

Technologies Available for Licensing

Share
Share
Technology Transfer Update
Receive email updates about current licensing opportunities.
Learn more

Memorial Sloan Kettering is developing an extensive assortment of technologies with applications for oncology and many other areas of healthcare and science. We offer opportunities for developing new devices, diagnostics, research tools, therapeutics, and vaccines.

Explore our list of technologies available for licensing below, and filter by technology categories.

Some of our newest technologies may not appear in this list. To learn about recent developments, contact any member of our staff about your particular interests.

Narrow your choices
Reset
41 Technologies found
SK2024-058
NKD1-Specific TCR Therapy for Metastatic Colorectal Cancer
This therapy leverages the fetal WNT developmental program that is reactivated during cancer progression and metastasis, providing a shared, scalable target for the majority of MSS mCRC patients. The TCR can be further developed into a cell therapy or a bispecific format.
SK2022-123
On-demand TNFRSF CD200R & PD1 Switch Receptors
With applicability to both approved hematologic products and emerging solid tumor programs, multi-switch receptor arrays offer a platform solution to enhance virtually any CAR T-cell therapy encountering tumor-mediated immune suppression.
SK2021-083
Pan-Cancer Reactive NDC80 CAR